Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Insurance topic
No spam. Unsubscribe anytime.
Highlands County workshop hears clinic‑centered plan to stabilize school health fund, presenters project $1.3M first‑year savings
Summary
Fleet and Marsh presented a clinic‑driven strategy to the Highlands County School Board workshop that would move most routine care into a district clinic network, raise plan deductibles and use direct contracting for drugs and imaging; presenters projected about $1.3 million in first‑year savings but employees warned higher deductibles and specialist access could be unaffordable for some staff.
Fleet program staff and a Marsh representative presented a clinic‑centered plan to the Highlands County School Board workshop that they said would slow the district's rising health costs and rebuild reserves.
The presenters said redirecting routine care through a managed clinic network, bolting on Marsh's direct pharmacy and provider contracts and running a targeted wellness program would reduce overall plan costs. "We're projecting a first‑year savings of about $1,300,000," the Marsh representative said, adding the estimate is conservative and depends on clinic engagement.
Why it matters: The district's current year funding was presented at about $17 million, and Fleet's modeling showed the plan could end the year roughly $2 million short at current claim trends. The presenters said the package — clinic management, plan redesign and a behavior‑change campaign — is intended to reverse that trajectory.
What the plan would change: Fleet described removing grandfathered benefit tiers, raising the individual deductible in the illustrative model to $8,500 (with a family out‑of‑pocket max modeled at $17,000), and using clinic‑provided services and direct contracts to limit deductible exposure for services the clinic can deliver. Marsh said its direct contracting approach cuts average specialty script cost examples (Marsh cited an average GLP‑1 script at roughly $1,113 in the district data versus direct pricing near $500) and that imaging and outpatient procedures could be routed to lower‑cost providers under clinic referrals.
Board and employee questions focused on access and affordability. Board members asked whether employees could continue to see long‑standing specialists and how telemedicine and clinic capacity would be managed. The presenters repeatedly said employees would be able to keep their own doctors, but that services not provided by the clinic would follow the district's normal deductible/coinsurance rules. On telemedicine and scheduling, Marsh said it would implement more active scheduling, telemedicine triage and monthly claims reporting so the district could identify and correct referrals outside the cost‑effective network.
Public comment and staff concerns: Several employees and union representatives said a higher deductible would be hard on low‑paid staff, asked whether the clinic provides pediatric and OB‑GYN coverage, and sought clarity about which medications (including GLP‑1 drugs and insulin) would be available at no or low cost through the clinic. One attendee summarized the risk succinctly: "If we don't do this, we keep losing millions and may have to cut staff; if we do it wrong, our employees could be priced out of care." Presenters acknowledged the tradeoffs and said some clinic services would be phased in, that pharmacy analyses would be provided, and that contractual guarantees would be written into any agreement.
Next steps: Fleet said any formal contract to have Marsh manage or supervise clinic services would return to the full board for approval (the presentation indicated a June board meeting for that action). Presenters also said board attorneys would review the contract language and that the contract would include measurable deliverables and a guaranteed ROI clause requiring the vendor to pay the district if deliverables were not met.
Details and numbers: Presenters used the district's prior‑year claims to model a $19.3 million baseline projection and estimated an initial 7.2% reduction in total plan cost under the clinic + direct contracting model. Marsh's charging model cited an $8 per employee per month fee for its program management within Fleet, which presenters said would be paid for by early redirections of care and could be delayed in billing for several months in the contract proposal.
What remains unresolved: The board and staff requested more granular pharmacy formularies, a list of clinic‑available specialties, and written contract language that spells out termination and remedy clauses if savings are not realized. Presenters agreed to return with a contract package, direct‑care pricing and more detailed pharmacy and service lists before the board votes.
